Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START New York Long Island, LLC Lake Success, New York, United States
View all 15 locations
View Trial Details
Recruiting

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

NCT05742607

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • St. Anthony's Hospital - BayCare Health System St. Petersburg, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Northwell Health Cancer Institute / Center for Novel Cancer Therapeutics Lake Success, New York, United States
View all 30 locations
View Trial Details
Recruiting

An External Control Arm Study in Non-Small Cell Lung Cancer

NCT07174388

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • Bayhealth Medical Center, Kent Campus Dover, Delaware, United States
  • Bayhealth Medical Center- Sussex Campus Milford, Delaware, United States
  • Northwest Oncology and Hematology Barrington, Illinois, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Conditions
Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
View Trial Details
Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details

Related conditions